TrialA Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects
Trial details
- Registry ID
- NCT05436288
- Phase
- Phase 2
KPRX
Kiora Pharmaceuticals, Inc.
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
4Trials in this database
0Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial DefectsNCT05436288 | KPRX | Phase 2 | Completed | 2022-12-22Actual |
| A Multi-Centre, Randomised, Controlled, Masked Phase 2 Study of the Safety and Efficacy of KIO-101 Ophthalmic Solution, Versus Vehicle Control in the Treatment of Dry Eye Disease in Patients With Autoimmune DiseaseNCT05629364 | KPRX | Phase 2 | Terminated | 2024-01-09Actual |
| A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis PigmentosaNCT06628947 | KPRX | Phase 2 | Recruiting | 2027-08Estimated |
| Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular EdemaNCT06825702 | KPRX | Phase 2 | Recruiting | 2026-11Estimated |
A Multi-Centre, Randomised, Controlled, Masked Phase 2 Study of the Safety and Efficacy of KIO-101 Ophthalmic Solution, Versus Vehicle Control in the Treatment of Dry Eye Disease in Patients With Autoimmune Disease
Trial details
- Registry ID
- NCT05629364
- Phase
- Phase 2
A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa
Trial details
- Registry ID
- NCT06628947
- Phase
- Phase 2
Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema
Trial details
- Registry ID
- NCT06825702
- Phase
- Phase 2
Latest recorded trial changes
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.